Why Is DAVITA INC (DVA) Stock Down Today?

Why DVA stock is down today

DaVita Inc. (DVA) fell 17.24% to $188.69 in the session, marking one of the largest single-day declines in its 52-week range of $101.00 to $247.49. The drop came despite the company reporting strong Q2 2026 results, including a rise in operating margin to 16.3% and positive cash flow. A key factor appears to be the company’s guidance for 2026, which included a projected $2.2 billion in adjusted operating income and $14.65 in earnings per share, but also flagged risks tied to ESRD reimbursement and lower revenue per treatment. The stock’s sharp decline suggests that investors may have been disappointed by the forward-looking risks or underwhelmed by the guidance relative to expectations.

What Happened

DaVita reported Q2 2026 results that showed improved operating performance, including a 6.7% year-over-year revenue increase and a 5.6% net margin. The company also reaffirmed its annual forecast despite signaling lower revenue per treatment. During the earnings call, executives highlighted the expansion of hemodialysis (HD) services but also noted ongoing challenges in the ESRD reimbursement landscape. The SEC 8-K filing on August 4 disclosed these results and reaffirmed the company’s financial outlook. Despite these positive fundamentals, the stock dropped significantly, with one report noting a 7% after-hours decline following the earnings release.

What The Data Shows

DaVita’s stock is trading at a P/E of 21.9, with a market cap of $15.0 billion. The recent drop has pushed the stock closer to its 52-week low of $101.00. In the last 36 hours, unusual options activity has been observed, with $7.9 million in call premiums traded and no put premiums. The largest single options print was $7.1 million. Additionally, Berkshire Hathaway sold 182,980 shares of DaVita at an average price of $199.55 per share on July 31, according to a recent SEC Form 4 filing. DaVita insiders, including CEO Javier Rodriguez and Chief Legal Officer Kathleen Waters, also sold shares in early June. Over the past 90 days, insiders have sold a total of $71.1 million in shares, with no insider purchases recorded.

What To Watch

Investors will need to monitor the company’s upcoming earnings date, which is not specified in the provided data, to assess whether the recent guidance and operational trends will continue to influence investor sentiment. Coverage breadth is also a factor, with seven stories from five sources published in the last 36 hours.